Innovative Patent Strengthens Nerve Mapping Technology for Cardiac Care

December 30, 2025 - 18:52

Autonomix has recently secured a new patent, EP4230133, which enhances its portfolio of over 80 issued patents focused on advanced medical technologies. This latest patent is a significant addition, as it covers closed-loop nerve mapping and therapy specifically targeting cardiac and other high-burden diseases.

The technology aims to revolutionize how healthcare professionals approach the treatment of conditions that affect the heart and other critical systems. By precisely mapping nerve pathways, the closed-loop system allows for targeted therapies that can improve patient outcomes significantly. The ability to address nerve-related issues in a closed-loop manner ensures that treatments are not only effective but also tailored to individual patient needs.

As the medical field continues to evolve, innovations like this patent represent a crucial step forward in the fight against complex diseases. Autonomix's commitment to developing cutting-edge solutions holds promise for enhancing the quality of life for patients suffering from heart-related ailments and beyond.